Optiver Holding B.V. Agios Pharmaceuticals, Inc. Transaction History
Optiver Holding B.V.
- $3.63 Billion
- Q2 2025
A detailed history of Optiver Holding B.V. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Optiver Holding B.V. holds 305 shares of AGIO stock, worth $13,169. This represents 0.0% of its overall portfolio holdings.
Number of Shares
305
Previous 215
41.86%
Holding current value
$13,169
Previous $6,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AGIO
# of Institutions
241Shares Held
61.8MCall Options Held
297KPut Options Held
235K-
Farallon Capital Management LLC San Francisco, CA5.77MShares$249 Million0.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.68MShares$245 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$210 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.59MShares$155 Million2.72% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.33MShares$100 Million0.65% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.37B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...